Location: New York, NY
CIK: 0001493215 · Show all filings
Period: Q3 2017 (← Previous) (Next →)
Filing Date: Nov 14, 2017
Total Value: $574M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | 623,338 | $73.24M | 12.8% | $75.05 | +13.7% | COM | 02043Q107 |
| PTCT | PTC Therapeutics Inc | 3,495,143 | $69.94M | 12.2% | $12.83 | +52.3% | COM | 69366J200 |
| BMY | Bristol Myers Squibb Co | 827,512 | $52.75M | 9.2% | $42.05 | +2.5% | COM | 110122108 |
| RGNX | Regenxbio Inc | 1,539,005 | $50.71M | 8.8% | $20.59 | +9.3% | COM | 75901B107 |
| — | Avexis Inc | 467,667 | $45.24M | 7.9% | $33.55 | — | COM | 05366U100 |
| — | La Jolla Pharmaceutical Co | 1,044,307 | $36.32M | 6.3% | $25.35 | — | COM PAR $.0001 2 | 503459604 |
| — | Achillion Pharmaceuticals In | 7,839,766 | $35.2M | 6.1% | $4.51 | — | COM | 00448Q201 |
| ABUS | Arbutus Biopharma Corp | 5,266,280 | $32.65M | 5.7% | $3.27 | +31.0% | COM | 03879J100 |
| — | Agenus Inc | 4,218,520 | $18.6M | 3.2% | $7.60 | — | COM NEW | 00847G705 |
| — | Corium Intl Inc | 1,675,479 | $18.56M | 3.2% | $7.94 | — | COM | 21887L107 |
| BCRX | BioCryst Pharmaceuticals | 3,324,705 | $17.42M | 3.0% | $7.25 | -29.4% | COM | 09058V103 |
| — | Oxford Immunotec Global PLC | 1,032,370 | $17.34M | 3.0% | $15.20 | — | ORD SHS | G6855A103 |
| — | bluebird bio Inc | 104,078 | $14.29M | 2.5% | $48.74 | — | COM | 09609G100 |
| OSUR | OraSure Technologies Inc | 535,707 | $12.05M | 2.1% | $10.50 | +91.7% | COM | 68554V108 |
| — | Dicerna Pharmaceuticals Inc | 2,078,991 | $11.95M | 2.1% | $13.12 | — | COM | 253031108 |
| TCMD | Tactile Sys Technology Inc | 353,216 | $10.93M | 1.9% | $17.26 | +83.4% | COM | 87357P100 |
| — | Myokardia Inc | 253,962 | $10.88M | 1.9% | $42.85 | — | COM | 62857M105 |
| — | Atara Biotherapeutics Inc | 656,018 | $10.86M | 1.9% | $17.06 | — | COM | 046513107 |
| MASI | Masimo Corp | 120,900 | $10.46M | 1.8% | $66.53 | +32.9% | COM | 574795100 |
| — | Viveve Med Inc | 1,473,028 | $7.719M | 1.3% | $4.99 | — | COM NEW | 92852W204 |
| VRAYQ | Viewray Inc | 1,020,462 | $5.878M | 1.0% | $5.80 | -2.8% | COM | 92672L107 |
| — | Spring Bk Pharmaceuticals In | 249,095 | $4.195M | 0.7% | $13.54 | — | COM | 849431101 |
| — | Bovie Medical Corp | 1,139,600 | $3.852M | 0.7% | $3.38 | — | COM | 10211F100 |
| — | Zynerba Pharmaceuticals Inc | 200,000 | $1.672M | 0.3% | $8.36 | — | COM | 98986X109 |
| — | Global Blood Therapeutics In | 26,310 | $817K | 0.1% | $35.72 | — | COM | 37890U108 |
| ARGX | argenx SE | 24,906 | $563K | 0.1% | $21.23 | — | SPONSORED ADR | 04016X101 |
| — | SENSUS HEATLHCARE INC | 155,000 | $90,000 | 0.0% | $0.50 | — | *W EXP 06/08/201 | 81728J117 |